DOV
64
-5
VNO
57
-2
FOXA
48
7
PPG
61
-5
AEP
58
2
FMC
40
4
THC
61
-3
GOOG
67
2
SO
66
2
AME
57
-2
DOW
58
-5
AN
50
-5
SCHW
52
3
KHC
59
14
VRSN
53
-2
ACN
56
13
NAVI
55
-2
BMY
56
3
LNC
52
2
DAL
62
-4
DOV
64
-5
VNO
57
-2
FOXA
48
7
PPG
61
-5
AEP
58
2
FMC
40
4
THC
61
-3
GOOG
67
2
SO
66
2
AME
57
-2
DOW
58
-5
AN
50
-5
SCHW
52
3
KHC
59
14
VRSN
53
-2
ACN
56
13
NAVI
55
-2
BMY
56
3
LNC
52
2
DAL
62
-4
Financhill
Back

PT Telkom Indonesia (Persero) Tbk Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
54

TLK
PT Telkom Indonesia (Persero) Tbk

Last Price:
20.58
Seasonality Move:
6.19%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
54
PT Telkom Indonesia (Persero) Tbk (TLK) is a Buy

Is PT Telkom Indonesia (Persero) Tbk a Buy, Sell or Hold?

  • The current PT Telkom Indonesia (Persero) Tbk [TLK] share price is $20.58. The Score for TLK is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • TLK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

TLK Stock Price Chart

What is PT Telkom Indonesia (Persero) Tbk's stock price today?

  • The PT Telkom Indonesia (Persero) Tbk share price today is $20.58
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TLK is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

TLK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 67.85 Buy
Chaikin Money Flow: -438216 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.16 - 20.22) Buy
Bollinger Bands (100): (17.94 - 19.72) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

TLK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.36 Buy
20-day SMA: 19.85 Buy
50-day SMA: 19.13 Buy
200-day SMA: 21.56 Sell
8-day EMA: 20.33 Buy
20-day EMA: 19.88 Buy
50-day EMA: 19.37 Buy
200-day EMA: 20.89 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

PT Telkom Indonesia (Persero) Tbk Earnings Growth & TLK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.11 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

PT Telkom Indonesia (Persero) Tbk Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):